Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline Re-treatment in Smokers
NCT01244061Phase 4Completed
- Sponsor
- Pfizer
- Start
- Dec 2010
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 4 trial of varenicline in nicotine dependence, sponsored by Pfizer. Started Dec 2010; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01244061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01244061.